Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.

Marius E MayerhoeferMarkus RadererUlrich JaegerPhilipp StaberBarbara KiesewetterDaniela SennFerdia A GallagherKevin BrindleEdit PorpaczyMichael WeberDominik BerzaczyIngrid Simonitsch-KluppChristian SillaberCathrin SkrabsAlexander Haug

Published in: European journal of nuclear medicine and molecular imaging (2018)

In lymphoma patients, [18F]FDG PET/MR can capture treatment-induced changes in glucose metabolism and cell density as early as 48-72 h after treatment initiation.

Keyphrases

pet ct
positron emission tomography
computed tomography
end stage renal disease
single cell
stem cells
chronic kidney disease
cell therapy
high resolution
ejection fraction
newly diagnosed
combination therapy
mass spectrometry
mesenchymal stem cells
patient reported outcomes